BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 6, 2004
View Archived Issues
XenoPort's Prodrug Efforts Yield $37M Equity Round
Read More
Biogen Idec, Celltech Team Up On CD40 Ligand Drugs
Read More
Nuvelo Adds Dendreon's Heart Product To Thickening Pipeline
Read More
Correction
Read More
Anika Wins Orthovisc Approval After Long Development Road
Read More
Other News To Note
Read More
Renovis Prices $66M IPO; SGI, Exact Pull In Follow-On Funds
Renovis Inc. entered the public arena as the third biotech company to conduct an initial public offering this year, raising $66 million. (BioWorld Today)
Read More